ArticleBMC health services research2016
Factors related to breast cancer detection mode and time to diagnosis in Alberta, Canada: a population-based retrospective cohort study.
Article in BMC health services research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Mammographic screening and time to breast cancer diagnosis among immigrants and long-term residents in Ontario.BMC cancer · 2026Article
- Impact of Immigration Status on Survival Among Stage 1 and 2 HER2-Positive and Triple-Negative Breast Cancer in Ontario, Canada.Cancer medicine · 2025Article
- Secondary use of routinely collected administrative health data for epidemiologic research: Answering research questions using data collected for a different purpose.International journal of population data science · 2024Article
- Breast Cancer Mode of Detection in a Population-Based Cohort.Mayo Clinic proceedings · 2023Article
- Assurance of Timely Access to Breast Cancer Diagnosis and Treatment by a Regional Breast Health Clinic Serving Both Urban and Rural-Remote Communities.Current oncology (Toronto, Ont.) · 2023Article
- From symptom to cancer diagnosis: Perspectives of patients and family members in Alberta, Canada.PloS one · 2020Article
- Determining the Cancer Diagnostic Interval Using Administrative Health Care Data in a Breast Cancer Cohort.JCO clinical cancer informatics · 2019Article
- Disparities in breast cancer diagnosis for immigrant women in Ontario and BC: results from the CanIMPACT study.BMC cancer · 2019Article
- Factors Associated with Initial Mode of Breast Cancer Detection among Black Women in the Women's Circle of Health Study.Journal of oncology · 2019Article
- Lessons Learned: It Takes a Village to Understand Inter-Sectoral Care Using Administrative Data across Jurisdictions.International journal of population data science · 2018Article
- Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2018Article
- Explaining time elapsed prior to cancer diagnosis: patients' perspectives.BMC health services research · 2017Article
- Breast cancer delay in Latinas: the role of cultural beliefs and acculturation.Journal of behavioral medicine · 2017Article
- Patient and disease characteristics, treatment practices and oncologic outcomes among patients with colorectal cancer: a population-based analysis.Canadian journal of surgery. Journal canadien de chirurgieArticle
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundUnderstanding the factors affecting the mode and timeliness of breast cancer diagnosis is important to optimizing patient experiences and outcomes. The purposes of the study were to identify factors related to the length of the diagnostic interval and assess how they vary by mode of diagnosis: screen or symptom detection.
methodsAll female residents of Alberta diagnosed with first primary breast cancer in years 2004-2010 were identified from the Alberta Cancer Registry. Data were linked to Physician Claims and screening program databases. Screen-detected patients were identified as having a screening mammogram within 6-months prior to diagnosis; remaining patients were considered symptom-detected. Separate quantile regression was conducted for each detection mode to assess the relationship between demographic/clinical and healthcare factors.
resultsOverall, 38 % of the 12,373 breast cancer cases were screen-detected compared to 47 % of the screen-eligible population. Health region of residence was strongly associated with cancer detection mode. The median diagnostic interval for screen and symptom-detected cancers was 19 and 21 days, respectively. The variation by health region, however, was large ranging from an estimated median of 4 to 37 days for screen-detected patients and from 17 to 33 days for symptom-detected patients. Cancer stage was inversely associated with the diagnostic interval for symptom-detected cancers, but not for screen-detected cancers.
conclusionSignificant variation by health region in both the percentage of women with screen-detected cancer and the length of the diagnostic interval for screen and symptom-detected breast cancers suggests there could be important differences in local breast cancer diagnostic care coordination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.